These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 20718729)
21. IMPDH1 promoter mutations in a patient exhibiting azathioprine resistance. Roberts RL; Gearry RB; Barclay ML; Kennedy MA Pharmacogenomics J; 2007 Oct; 7(5):312-7. PubMed ID: 17001353 [TBL] [Abstract][Full Text] [Related]
22. Inosine monophosphate dehydrogenase type1 sustains tumor growth in hepatocellular carcinoma. Jia X; Liu Y; Cheng Y; Wang Y; Kang H; Ma Z; Chen K J Clin Lab Anal; 2022 May; 36(5):e24416. PubMed ID: 35403278 [TBL] [Abstract][Full Text] [Related]
23. Mycophenolic acid inhibits oleic acid-induced mesangial cell activation through both cellular reactive oxygen species and inosine monophosphate dehydrogenase 2 pathways. Huh KH; Ahn HJ; Park J; Ju MK; Song JS; Kim MS; Kim SI; Kim YS Pediatr Nephrol; 2009 Apr; 24(4):737-45. PubMed ID: 19093139 [TBL] [Abstract][Full Text] [Related]
24. Mycophenolic acid displays IMPDH-dependent and IMPDH-independent effects on renal fibroblast proliferation and function. Petrova DT; Brandhorst G; Brehmer F; Gross O; Oellerich M; Armstrong VW Ther Drug Monit; 2010 Aug; 32(4):405-12. PubMed ID: 20592645 [TBL] [Abstract][Full Text] [Related]
25. Genetic variations in the HGPRT, ITPA, IMPDH1, IMPDH2, and GMPS genes in Japanese individuals. Kudo M; Saito Y; Sasaki T; Akasaki H; Yamaguchi Y; Uehara M; Fujikawa K; Ishikawa M; Hirasawa N; Hiratsuka M Drug Metab Pharmacokinet; 2009; 24(6):557-64. PubMed ID: 20045992 [TBL] [Abstract][Full Text] [Related]
26. Expression of IMPDH mRNA after mycophenolate administration in male volunteers. Kim S; Lee W; Chun S; Um TH; Min WK Biomed Res Int; 2014; 2014():870209. PubMed ID: 25105143 [TBL] [Abstract][Full Text] [Related]
27. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine. Vethe NT; Bremer S; Bergan S Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073 [TBL] [Abstract][Full Text] [Related]
28. Highly selective inhibition of IMPDH2 provides the basis of antineuroinflammation therapy. Liao LX; Song XM; Wang LC; Lv HN; Chen JF; Liu D; Fu G; Zhao MB; Jiang Y; Zeng KW; Tu PF Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5986-E5994. PubMed ID: 28674004 [TBL] [Abstract][Full Text] [Related]
29. Simultaneous quantification of IMPDH activity and purine bases in lymphocytes using LC-MS/MS: assessment of biomarker responses to mycophenolic acid. Vethe NT; Ali AM; Reine PA; Andersen AM; Bremer S; Line PD; Rootwelt H; Bergan S Ther Drug Monit; 2014 Feb; 36(1):108-18. PubMed ID: 24061448 [TBL] [Abstract][Full Text] [Related]
30. Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphism. Sombogaard F; van Schaik RH; Mathot RA; Budde K; van der Werf M; Vulto AG; Weimar W; Glander P; Essioux L; van Gelder T Pharmacogenet Genomics; 2009 Aug; 19(8):626-34. PubMed ID: 19617864 [TBL] [Abstract][Full Text] [Related]
31. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives. Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342 [TBL] [Abstract][Full Text] [Related]
32. Polymorphisms in IMPDH2, UGT2B7, and CES2 genes influence the risk of graft rejection in kidney transplant recipients taking mycophenolate mofetil. Cilião HL; Camargo-Godoy RBO; Souza MF; Zanuto A; Delfino VDA; Cólus IMS Mutat Res Genet Toxicol Environ Mutagen; 2018 Dec; 836(Pt B):97-102. PubMed ID: 30442353 [TBL] [Abstract][Full Text] [Related]
34. Genetic variations in the mycophenolate mofetil target enzyme are associated with acute GVHD risk after related and unrelated hematopoietic cell transplantation. Cao W; Xiao H; Lai X; Luo Y; Shi J; Tan Y; Zheng W; He J; Xie W; Li L; Ye X; Yu X; Lin M; Cai Z; Huang H Biol Blood Marrow Transplant; 2012 Feb; 18(2):273-9. PubMed ID: 21745452 [TBL] [Abstract][Full Text] [Related]
35. Effects of inosine monophosphate dehydrogenase inhibition on high glucose-induced cellular reactive oxygen species in mesangial cells. Song JS; Huh KH; Park J; Ju MK; Kim MS; Kim YS Transplant Proc; 2008 Mar; 40(2):464-6. PubMed ID: 18374103 [TBL] [Abstract][Full Text] [Related]
36. Spectrum and frequency of mutations in IMPDH1 associated with autosomal dominant retinitis pigmentosa and leber congenital amaurosis. Bowne SJ; Sullivan LS; Mortimer SE; Hedstrom L; Zhu J; Spellicy CJ; Gire AI; Hughbanks-Wheaton D; Birch DG; Lewis RA; Heckenlively JR; Daiger SP Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):34-42. PubMed ID: 16384941 [TBL] [Abstract][Full Text] [Related]
37. IMPDH dysregulation in disease: a mini review. Burrell AL; Kollman JM Biochem Soc Trans; 2022 Feb; 50(1):71-82. PubMed ID: 35191957 [TBL] [Abstract][Full Text] [Related]
38. Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid. Sintchak MD; Fleming MA; Futer O; Raybuck SA; Chambers SP; Caron PR; Murcko MA; Wilson KP Cell; 1996 Jun; 85(6):921-30. PubMed ID: 8681386 [TBL] [Abstract][Full Text] [Related]
39. Isolation and characterization of mycophenolic acid-resistant mutants of inosine-5'-monophosphate dehydrogenase. Farazi T; Leichman J; Harris T; Cahoon M; Hedstrom L J Biol Chem; 1997 Jan; 272(2):961-5. PubMed ID: 8995388 [TBL] [Abstract][Full Text] [Related]
40. Mycophenolic Acid Derivatives with Immunosuppressive Activity from the Coral-Derived Fungus Zhang Q; Yang B; Li F; Liu M; Lin S; Wang J; Xue Y; Zhu H; Sun W; Hu Z; Zhang Y Mar Drugs; 2018 Jul; 16(7):. PubMed ID: 29986508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]